Loading live market data…

Avanos Medical, Inc.

NYSE:AVNS

$24.98 USD

$0.05 (0.2%)

Volume
162.57K
Average Volume
1.67M
Market Capitalization
$1.17B
P/E Ratio
-16.65
Dividend Yield
0.00%
Price Target
$23.00
Year High
$25.49
Year Low
$9.30
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.48
Source Headline
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger

ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").

prnewswire.com - 2026-07-02 10:00:00

Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?

Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026

gurufocus.com - 2026-06-25 14:00:00

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (“KSF”) are investigating the propos

gurufocus.com - 2026-06-24 15:00:00

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.

businesswire.com - 2026-06-24 14:54:00

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.

zacks.com - 2026-06-24 10:50:41

Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

prnewswire.com - 2026-06-12 11:47:00

The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—TMHC, CZR, XOMA, and AVNS

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

globenewswire.com - 2026-06-11 16:16:49

Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:31:18

Are CZR, AVNS, GBTG Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

prnewswire.com - 2026-06-01 15:26:00

$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger--AFBI, QXO, BLD, and AVNS

$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger--AFBI, QXO, BLD, and AVNS PR Newswire

gurufocus.com - 2026-06-01 15:00:00

New Strong Sell Stocks for May 15th

AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.

zacks.com - 2026-05-15 07:06:12

Deciphering Avanos Medical (AVNS) International Revenue Trends

Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

zacks.com - 2026-05-11 10:16:32

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.

zacks.com - 2026-05-07 12:35:11

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Helix Energy Solutions Group, Inc. (NYSE – HLX), TopBuild Corp. (NYSE – BLD), Avanos Medical, Inc. (NYSE – AVNS), Affinity Bancshares (Nasdaq – AFBI)

BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith. com) or Marc Ackerman (mackerman@brodskysmith. com) at 855-576-4847.

globenewswire.com - 2026-05-05 15:02:36

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.

zacks.com - 2026-05-05 09:26:34

Avanos Medical, Inc. Announces First Quarter 2026 Results

Delivered double-digit organic growth led by Specialty Nutrition Systems segment Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per share On April 14, 2026, announced the execution of a definitive agreement to be acquired by certain affiliates of American Industrial Partners ("AIP") in an all-cash offer at an enterprise value of $1.272 billion ALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.

prnewswire.com - 2026-05-05 07:00:00

Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, April 23, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial.

globenewswire.com - 2026-04-23 08:03:00

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that le.

businesswire.com - 2026-04-15 12:02:00

Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium

AVNS stock jumps after agreeing to a $1.27B all-cash buyout by AIP at a 72% premium, offering shareholders immediate value and setting up a private-market shift.

zacks.com - 2026-04-15 10:56:29

Get AVNS Insider Trade Alerts

AVNS Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$27.00

5 analysts

AVNS Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2023-07-25 Keybanc Downgrade Overweight Sector Weight
2023-06-21 Stifel Maintain Hold Hold
2023-05-04 Morgan Stanley Maintain Underweight Underweight
2023-02-22 Morgan Stanley Maintain Underweight Underweight
2023-01-06 Morgan Stanley Maintain Underweight Underweight
2022-11-03 Keybanc Maintain Overweight Overweight
2022-10-11 Morgan Stanley Maintain Underweight Underweight
2022-08-10 Keybanc Maintain Overweight Overweight
2022-07-18 Stifel Maintain Hold Hold
2022-07-15 Morgan Stanley Maintain Underweight Underweight
2022-05-05 Morgan Stanley Maintain Underweight Underweight
2022-02-24 Keybanc Maintain Overweight Overweight
2022-01-07 Morgan Stanley Maintain Underweight Underweight
2021-08-04 Keybanc Maintain Overweight Overweight
2021-08-04 Morgan Stanley Maintain Underweight Underweight
2021-08-04 Stephens & Co. Downgrade Overweight Equal Weight
2021-01-08 KeyBanc Maintain Overweight Overweight
2020-12-15 Morgan Stanley Maintain Underweight Underweight
2020-11-04 Morgan Stanley Maintain Underweight Underweight
2020-11-04 Keybanc Maintain Overweight Overweight
2020-11-04 KeyBanc Maintain Overweight Overweight
2020-08-05 Keybanc Maintain Overweight Overweight
2020-08-05 KeyBanc Maintain Overweight Overweight
2020-05-07 Morgan Stanley Maintain Underweight Underweight
2020-04-27 KeyBanc Maintain Overweight Overweight
2020-04-27 Keybanc Maintain Overweight Overweight
2020-04-13 Barclays Upgrade Underweight Equal Weight
2020-04-01 Stifel Maintain Hold Hold
2020-03-27 Morgan Stanley Maintain Underweight Underweight
2020-03-23 Stephens & Co. Maintain Overweight Overweight
2019-12-17 Morgan Stanley Maintain Underweight Underweight
2019-11-07 Stifel Downgrade Buy Hold
2019-11-07 Stifel Nicolaus Downgrade Buy Hold
2019-11-06 Raymond James Downgrade Outperform Market Perform
2019-11-06 KeyBanc Maintain Overweight Overweight
2019-11-06 Keybanc Maintain Overweight Overweight
2019-08-07 Raymond James Maintain Outperform Outperform
2019-02-27 Keybanc Maintain Overweight Overweight
2019-02-27 KeyBanc Maintain Overweight Overweight
2019-01-04 Barclays Downgrade Equal Weight Underweight
2018-12-18 KeyBanc Maintain Overweight Overweight
2018-12-18 Keybanc Maintain Overweight Overweight
2018-10-11 Morgan Stanley Maintain Underweight Underweight
2018-08-21 Raymond James Upgrade Market Perform Outperform
2018-08-08 Keybanc Maintain Overweight Overweight
2018-08-08 KeyBanc Maintain Overweight Overweight
2018-08-08 Morgan Stanley Maintain Underweight Underweight